The Effects of Manual Therapy on the Spatiotemporal Gait Characteristics in Patients With Chronic Obstructive Pulmonary Disease

Официальное название

An Investigation of the Effects of Manual Therapy on the Spatiotemporal Gait Characteristics in Patients With Chronic Obstructive Pulmonary Disease

Обзор

The primary aim of this study is to investigate the effects of manual therapy on spatiotemporal characteristics of gait and gait variability, functional exercise capacity, and pulmonary function in patients with chronic obstructive pulmonary disease (COPD). The secondary aims of the study are to determine the effects of manual therapy on balance, respiratory muscle strength, quality of life, physical activity, symptom severity, accessory respiratory muscle activation, peripheral muscle strength, chest wall mobility, dysfunctional breathing, pain, and posture.

Подробное описание

Musculoskeletal changes secondary to systemic inflammation in chronic obstructive pulmonary disease (COPD) negatively affect both ventilatory efficiency and ventilation-perfusion matching during walking, leading to a reduction in functional capacity. Current and conventional pulmonary rehabilitation approaches generally aim to improve aerobic capacity, muscle strength, and respiratory muscle endurance. However, aspects such as thoracic spine mobility, costotransverse and costovertebral joint biomechanics, the craniocaudal positioning of the diaphragm, and accessory respiratory muscle activation are still not adequately addressed in existing rehabilitation programs. The effects of manual therapy applied to the thoracic region, trunk, and accessory respiratory muscles on both exercise capacity and the spatiotemporal characteristics of gait have not yet been clearly established. Given the multisystem involvement in COPD, the application of manual therapy-an intervention with a high level of evidence in the management of other musculoskeletal conditions-offers an innovative approach to treatment. It is plausible that muscle energy techniques, one of the manual therapy methods, may reduce hypertonicity in excessively activated accessory respiratory muscles during breathing and thereby enhance chest wall expansion. In the existing literature, the limited number of studies investigating manual therapy interventions in COPD have primarily focused on pulmonary function and exercise capacity; however, there is still no consensus regarding the outcomes. Considering the biomechanical connection between the thoracic cage and the trunk and extremities, it can be hypothesized that manual therapies in COPD may influence gait by affecting lower extremity movements. In this context, manual therapy may impact not only respiratory parameters but also gait performance through the interaction between biomechanics, respiration, and posture in patients with COPD.

Вмешательства

• Другое Manual therapy Group
  For muscle energy techniques, the post-isometric relaxation (PIR) technique will be applied. Participants will be instructed to perform an isometric contraction against mild resistance (20-30% of maximal effort), which will be maintained for 7-10 seconds, followed by a 3-second relaxation period. PIR applications will be performed bilaterally for each muscle group, in 2 sets with a total of 10 repetitions. The muscle groups to which MET will be applied include the pectoralis major and minor, upp
• Другое Control group
  Self-stretching and breathing exercise

Первичные конечные точки

• Spatiotemporal Gait Characteristics (Gait Analysis) [Срок оценки: At the baseline and after the eight-week intervention]
• Spatial Gait Distance Parameters [Срок оценки: At the baseline and after the eight-week intervention]
• Temporal Gait Parameters [Срок оценки: At the baseline and after the eight-week intervention]
• Gait Speed [Срок оценки: At the baseline and after the eight-week intervention]
• Cadence [Срок оценки: At the baseline and after the eight-week intervention]
• Gait Symmetry and Asymmetry Indices [Срок оценки: At the baseline and after the eight-week intervention]
• Gait Variability Parameters [Срок оценки: At the baseline and after the eight-week intervention]
• Functional exercise capacity [Срок оценки: At the baseline and after the eight-week intervention]
• Pulmonary Functions [Срок оценки: At baseline and after the eight-week intervention]
• Forced Vital Capacity (FVC) [Срок оценки: At the baseline and after the eight-week intervention]

Вторичные конечные точки (12)

• Respiratory muscle strength [Срок оценки: At the baseline and after the eight-week intervention]
• Peripheral muscle strength [Срок оценки: At the baseline and after the eight-week intervention]
• Balance assessment [Срок оценки: At the baseline and after the eight-week intervention]
• Accessory Muscle activation [Срок оценки: At the baseline and after the eight-week intervention]
• Posture [Срок оценки: At the baseline and after the eight-week intervention]
• Chest wall assessment [Срок оценки: At the baseline and after the eight-week intervention]
• Dyspnea Level [Срок оценки: At the baseline and after the eight-week intervention]
• Severity of symptoms [Срок оценки: At the baseline and after the eight-week intervention]
• Severity of disease [Срок оценки: At the baseline and after the eight-week intervention]
• Severity of disease and mortality [Срок оценки: At the baseline and after the eight-week intervention]
• Quality of life (St. George's Respiratory Questionnaire ) [Срок оценки: At the baseline and after the eight-week intervention]
• Physical Activity (International Physical Activity Questionnaire) [Срок оценки: At the baseline and after the eight-week intervention]

Критерии участия

Критерии включения

• Age 40 years or older
• Clinically stable for at least the past 4 weeks
• Classified as GOLD stage 1, 2, or 3 according to the Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) airflow limitation classification
• Classified as group A, B, or E according to the GOLD ABE assessment tool

Критерии исключения

• Use of walking assistive devices
• Receiving long-term oxygen therapy
• Presence of additional orthopedic, neuromuscular, neurological, or cardiac conditions that may affect gait and balance
• History of lung cancer, sarcoidosis, tuberculosis, and/or lung surgery
• Presence of musculoskeletal conditions such as fibromyalgia, rheumatoid arthritis, or osteoarthritis
• Presence of a known mental or cognitive impairment

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение

Рандомизированное

Модель

Параллельные группы

Маскирование

Двойное слепое

Основная цель

Лечение

Центры проведения

Turkey (Türkiye) · 1 центр

• Hacettepe University — Ankara

Идентификаторы

NCT: NCT07381842 · FTREK25/173

Первоисточники (государственные реестры)

• ClinicalTrials.gov (NIH, США)

Открыть это исследование на ClinicalTrials.gov ↗